After viewing this webinar, you will be able to :
- Review what we know now about COVID-19 and the situation locally and globally
- Interpret the serological evidence and how COVID-19 infection is spreading
- Understand how SARS-CoV-2 has evolved and the variants and subvariants now in the population
- Review the disease course in patients with mild and severe symptoms, long COVID-19 and other post-COVID-19 syndromes.
- Detail current vaccination strategies, the use of antivirals and future pipeline vaccines
Speaker
Professor Gary Grohmann
Gary Grohmann is a virologist and a former Director of Immunobiology (a WHO Essential Regulatory Laboratory) at the Therapeutic Goods Administration (TGA) in Australia (1997- 2015), responsible for vaccine testing and registration. Prior to working for the TGA he worked for the University of Sydney in the Faculty of Veterinary Sciences as Reader/Associate Professor working on public health and environmental issues where he also was engaged by the NSW EPA and the Auckland Regional council as an independent expert witness on a number of important landmark environmental court cases (1996-00). He is currently an independent consultant with Environmental Pathogens based in Canberra, a consultant with Biointelect and a board member/director of the Immunisation coalition in Australia; his interests are in the areas of Virology, Vaccination and control of infectious diseases, pandemic planning, influenza, regulatory issues, environmental virology, electron microscopy and gastrointestinal viruses. He became a Fellow of the Australian Society for Microbiology in 1989. He has recently joined the executive board of AVM Biotechnology in the USA, advising on projects involving dexamethasone treatments.
Moderator
Dr. Andrew Minton, PhD
Andrew brings a wealth of experience in medical education, medical information, and pharmaceutical industry expertise across various disease areas. His background uniquely positions him to contribute significantly to the Immunisation Coalition. In his role, Andrew is responsible for developing both accredited and non-accredited infectious disease education programs for healthcare professionals (HCPs).